Concurrent crack and powder cocaine users from Sao Paulo: Do they represent a different group?
Tóm tắt
Cocaine abuse is a serious and socially damaging illegal drug problem. Different routes of administration are associated with a specific progression of use, different degrees of abuse liability, propensity for dependence and treatment response. There have been relatively few studies comparing different cocaine users groups and no studies into the characterization of the group of individuals reporting concurrent use of powder cocaine and crack cocaine. Six hundred and ninety-nine cocaine users were assessed during the period August 1997 to October 1998 in one outpatient and six inpatient clinics located in the São Paulo, Brazil. Patients were interviewed using a structured questionnaire schedule in Portuguese, designed specifically for the Brazilian population. The statistical analyses were performed using either ANOVA or a chi-squared test and focusing on their preferred form of use/route of administration and other variables. For 83% of the variables tested in this study, the Dual Users subgroup (using both powder and crack cocaine) demonstrated statistical differences from the single drug user subgroups. Those differences include the initiation of cocaine, the abuse of other illicit drugs, and rates of criminal history. These data suggest cocaine-dependent individuals who report use of both powder and crack cocaine are an at least partially, distinct subgroup. However, further studies will be necessary to confirm this and to determine if they also show a different treatment response.
Tài liệu tham khảo
Substance Abuse and mental Health Service Administration (SAMHSA): National Household Survey on Drug Abuse (NHSDA). 2003, Report
Haasen C, Prinzleve M, Zurhold H, Rehm J, Guttinger F, Fischer G, Jagsch R, Olsson B, Ekendahl M, Verster A, Camposeragna A, Pezous AM, Gossop M, Manning V, Cox G, Ryder N, Gerevich J, Bacskai E, Casas M, Matali JL, Krausz M: Cocaine use in Europe – a multi-centre study. Methodology and prevalence estimates. Eur Addict Res. 2004, 10 (4): 139-46. 10.1159/000079834.
Galduroz JCF, Noto AR, Nappo S, Carlini EA: I National Survey on psychotropic drugs use. Part A: Study of the 24 biggest cities of the Sao Paulo State. CEBRID (Centro Brasileiro de Informações sobre Drogas Psicotrópicas), UNIFESP – Federal University of São Paulo. 2000
Gossop M, Griffiths P, Powis B, Strang J: Cocaine: patterns of use, route of administration, and severity of dependence. Br J Psychiatry. 1994, 164 (5): 660-4.
Gossop M, Marsden J, Stewart D, Kidd T: The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction. 2003, 98 (3): 291-303. 10.1046/j.1360-0443.2003.00296.x.
Chen CY, Anthony JC: Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine. Psychopharmacology. 2004, 172: 78-86. 10.1007/s00213-003-1624-6.
Dunn J, Laranjeira RR, Da Silveira DX, Formigoni ML, Ferri CP: Crack cocaine: an increase in use among patients attending clinics in Sao Paulo: 1990–1993. Subst Use Misuse. 1996, 31: 519-27.
Dunn J, Laranjeira RR: Transitions in the route of cocaine administration – characteristics, direction and associated variables. Addiction. 1999, 94 (6): 813-24. 10.1046/j.1360-0443.1999.9468135.x.
Ferri CP, Gossop M: Route of cocaine administration: patterns of use and problems among a Brazilian sample. Addict Behav. 1999, 24: 815-21. 10.1016/S0306-4603(99)00036-2.
Ferri CP, Gossop M, Laranjeira RR: High dose cocaine use in Sao Paulo: a comparison of treatment and community samples. Subst Use Misuse. 2001, 36: 237-55. 10.1081/JA-100102624.
Ferri CP, Dunn J, Gossop M, Laranjeira R: Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in Sao Paulo, Brazil. Addict Behav. 2004, 29 (2): 365-74. 10.1016/j.addbeh.2003.08.029.
Ferreira Filho OF, Turchi MD, Laranjeira R, Castelo A: Epidemiological profile of Powder Cocaine Users on treatment in psychiatrics hospitals, Brazil. Rev Saude Publica. 2003, 37: 751-9.
Dunn J, Ferri CP, Laranjeira R: Does multisite sampling improve patient heterogeneity in drug misuse research?. Drug Alcohol Depend. 2001, 63: 79-85. 10.1016/S0376-8716(00)00192-7.
Dunn J, Laranjeira R: The development of a structured interview to evaluate cocaine use and risk behaviour. Rev Bras Psiquiatr. 2000, 22 (1): 11-6. 10.1590/S1516-44462000000100004.
Turchi MD, Diaz RS, Martelli Turchi, Sabino EC, da Silva WP, Filho OF, Laranjeira RR, Busch MP, Castelo A: Genetic Diversity and HIV-1 Incidence Estimation Among Powder Cocaine Users in Sao Paulo, Brazil. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2002, 30: 527-532.
WHO: The ICD10 classification of mental and behavioural disorders. Diagnostic criteria for research. 1993
Hatsukami DK, Fischman MW: Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?. JAMA. 1996, 276: 1580-8. 10.1001/jama.276.19.1580.
Condon J, Smith N: Prevalence of drug use: key findings from the 2002/2003 British Crime Survey. Home Office. 2003, [http://www.crimereduction.gov.uk/drugsalcohol75.htm#Prevalence]
Grant BF, Harford TC: Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend. 1990, 25 (1): 97-104. 10.1016/0376-8716(90)90147-7.
McCance-Katz EF, Kosten TR, Jatlow P: Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone – a multiple-dose study. Biol Psychiatry. 1998, 44: 250-9. 10.1016/S0006-3223(97)00426-5.
Farre M, De La Torre R, Llorente M, Lamas X, Balbina U, Segura J, Cami J: Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther. 1993, 266: 1364-1373.
Prinzleve M, Haasen C, Zurhold H, Matali JL, Bruguera E, Gerevich J, Bacskai E, Ryder N, Butler S, Manning V, Gossop M, Pezous AM, Verster A, Camposeragna A, Andersson P, Olsson B, Primorac A, Fischer G, Guttinger F, Rehm J, Krausz M: Cocaine use in Europe – a multi-centre study: patterns of use in different groups. Eur Addict Res. 2004, 10 (4): 147-10.1159/000079835.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Annual report on the state of the drugs problem in the European Union. 2004
U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network 2003: Interim National Estimates of Drug-Related Emergency Department Visits. 2004
Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction. 2003, 98 (6): 739-47. 10.1046/j.1360-0443.2003.00376.x.
Seymour A, Oliver JS, Black M: Drug-related deaths among recently released prisoners in the Strathclyde Region of Scotland. Journal of Forensic Sciences. 2000, 45: 649-654.
Asnis GM, Kaplan ML, Hundorfean G, Saeed W: Violence and homicidal behaviours in psychiatric disorders. Psychiatr Clin North Am. 1997, 20: 405-25. 10.1016/S0193-953X(05)70320-8.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/6/10/prepub